Tag: Merck’s Keytruda

MRNA shares rose as high as 9% during the day, continuing their recent steady climb. This was enough for MRNA to lead the S&P 500’s list of top movers on Tuesday. The company presented details at the annual American Association for Cancer Research meeting on Monday. Here, it revealed interesting data on the use of…